173 related articles for article (PubMed ID: 24755231)
1. NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis.
Agúndez JA; García-Martín E; Martínez C; Benito-León J; Millán-Pascual J; Calleja P; Díaz-Sánchez M; Pisa D; Turpín-Fenoll L; Alonso-Navarro H; Ayuso-Peralta L; Torrecillas D; Plaza-Nieto JF; Jiménez-Jiménez FJ
BMC Neurol; 2014 Apr; 14():87. PubMed ID: 24755231
[TBL] [Abstract][Full Text] [Related]
2. Genetic association of the NQO1 rs1800566 (609C>T) variant with risk of preeclampsia in the Chinese Han population.
Zhao L; Liu J; Tan P; Zhang W; Gao Q; Li X; Lin Y; Dong Q; Wang H; Liu S
Pregnancy Hypertens; 2017 Oct; 10():42-45. PubMed ID: 29153688
[TBL] [Abstract][Full Text] [Related]
3. Combined GSTP1 and NQO1 germline polymorphisms in the susceptibility to Multiple Sclerosis.
Alexoudi A; Zachaki S; Stavropoulou C; Chatzi I; Koumbi D; Stavropoulou K; Kollia P; Karageorgiou CE; Sambani C
Int J Neurosci; 2015 Jan; 125(1):32-7. PubMed ID: 24588223
[TBL] [Abstract][Full Text] [Related]
4. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
Zhang H; Wen X; Lu X; Zhang H
Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.
Freriksen JJ; Salomon J; Roelofs HM; Te Morsche RH; van der Stappen JW; Dura P; Witteman BJ; Lacko M; Peters WH
J Hum Genet; 2014 Jul; 59(7):381-6. PubMed ID: 24830960
[TBL] [Abstract][Full Text] [Related]
6. NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.
Yin J; Wang L; Wang X; Zheng L; Shi Y; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H
Scand J Gastroenterol; 2014 Mar; 49(3):317-22. PubMed ID: 24354914
[TBL] [Abstract][Full Text] [Related]
7. NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample: A STROBE-complaint case-control study.
Yang S; Zhao J; Li L
Medicine (Baltimore); 2020 May; 99(20):e19941. PubMed ID: 32443295
[TBL] [Abstract][Full Text] [Related]
8. Possible Implication of GSTP1 and NQO1 Polymorphisms on Natalizumab Response in Multiple Sclerosis.
Alexoudi A; Zachaki S; Stavropoulou C; Gavrili S; Spiliopoulou C; Papadodima S; Karageorgiou CE; Sambani C
Ann Clin Lab Sci; 2016 Dec; 46(6):586-591. PubMed ID: 27993870
[TBL] [Abstract][Full Text] [Related]
9. The C609T inborn polymorphism in NAD(P)H:quinone oxidoreductase 1 is associated with susceptibility to multiple sclerosis and affects the risk of development of the primary progressive form of the disease.
Stavropoulou C; Zachaki S; Alexoudi A; Chatzi I; Georgakakos VN; Terzoudi GI; Pantelias GE; Karageorgiou CE; Sambani C
Free Radic Biol Med; 2011 Aug; 51(3):713-8. PubMed ID: 21605663
[TBL] [Abstract][Full Text] [Related]
10. Association of Genetic Variations in NRF2, NQO1, HMOX1, and MT with Severity of Coronary Artery Disease and Related Risk Factors.
Sarutipaiboon I; Settasatian N; Komanasin N; Kukongwiriyapan U; Sawanyawisuth K; Intharaphet P; Senthong V; Settasatian C
Cardiovasc Toxicol; 2020 Apr; 20(2):176-189. PubMed ID: 31332605
[TBL] [Abstract][Full Text] [Related]
11. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
12. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.
Ding R; Lin S; Chen D
Int J Colorectal Dis; 2012 Jul; 27(7):885-92. PubMed ID: 22215148
[TBL] [Abstract][Full Text] [Related]
13. Genetic association of NAD(P)H quinone oxidoreductase (NQO1*2) polymorphism with NQO1 levels and risk of diabetic nephropathy.
Sharma M; Mehndiratta M; Gupta S; Kalra OP; Shukla R; Gambhir JK
Biol Chem; 2016 Aug; 397(8):725-30. PubMed ID: 27078674
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India.
Mandal RK; Nissar K; Mittal RD
Mol Biol Rep; 2012 Dec; 39(12):11145-52. PubMed ID: 23054000
[TBL] [Abstract][Full Text] [Related]
15. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.
Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R
Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831
[TBL] [Abstract][Full Text] [Related]
17. The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects.
Guo ZJ; Feng CL
Asian Pac J Cancer Prev; 2012; 13(12):6343-8. PubMed ID: 23464456
[TBL] [Abstract][Full Text] [Related]
18. Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence.
Liu H; Zhang W; Deng XD; Ma Y; Liu Y
Mol Genet Genomic Med; 2021 Oct; 9(10):e1789. PubMed ID: 34467676
[TBL] [Abstract][Full Text] [Related]
19. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population.
Liu F; Luo L; Wei Y; Wang W; Li B; Yan L; Wen T
Tumour Biol; 2013 Feb; 34(1):47-53. PubMed ID: 22972504
[TBL] [Abstract][Full Text] [Related]
20. Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation.
Li J; Yang W; Xie Z; Yu K; Chen Y; Cui K
BMC Cardiovasc Disord; 2018 May; 18(1):96. PubMed ID: 29776386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
